Multifactorial cardiovascular disease prevention in patients aged 75 years and older: A randomized controlled trial
- 1 December 2001
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 142 (6), 945-951
- https://doi.org/10.1067/mhj.2001.119609
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Use of cardiovascular drugs by home-dwelling coronary patients aged 75 years and olderEuropean Journal of Clinical Pharmacology, 2001
- CARDIOVASCULAR AGING IN HEALTHClinics in Geriatric Medicine, 2000
- Cholesterol Lowering in the Elderly PopulationArchives of Internal Medicine, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trialThe Lancet, 1998
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Hypertension in the ElderlyPublished by American Medical Association (AMA) ,1994
- Self‐Reported Causes of Physical Disability in Older People: The Cardiovascular Health StudyJournal of the American Geriatrics Society, 1994